10-Q: Ascend Wellness Holdings Reports Third Quarter 2024 Results, Revenue Flat Year-Over-Year

Ascend Wellness Holdings' third quarter 2024 results show flat revenue compared to the same period last year, with a net loss driven by increased operating expenses.

Summary

• Ascend Wellness Holdings reported a net revenue of $141.6 million for the third quarter of 2024, which is nearly identical to the $141.3 million reported in the same quarter of 2023.
• The company experienced an operating loss of $2.4 million in Q3 2024, a decrease from the $3.5 million operating profit in Q3 2023.
• The net loss for the quarter was $28.3 million, compared to a net loss of $11.2 million in the third quarter of 2023.
• For the nine months ended September 30, 2024, the company's net loss was $68.2 million, compared to a net loss of $28.9 million for the same period in 2023.
• The company's gross profit margin was 30.9% for the third quarter of 2024, slightly up from 30.8% in the same period of 2023.
• Operating expenses increased to $46.1 million in Q3 2024, up from $40 million in Q3 2023.
• The company's cash and cash equivalents decreased to $65.3 million as of September 30, 2024, from $72.5 million at the end of 2023.
• The company refinanced a portion of its debt, issuing $235 million in senior secured notes and using the proceeds to prepay $215 million of existing debt.

Sentiment

Score: 4

Explanation: The document presents mixed results with flat revenue growth and a significant increase in net loss. While the company is taking steps to manage its debt and expand into new markets, the overall financial performance is concerning, leading to a negative sentiment.

Positives

• The company's wholesale revenue increased due to expansion in certain markets, particularly in New Jersey and Massachusetts.
• The company recognized incremental revenue from acquisitions and the commencement of non-medical sales in Ohio.
• The company generated positive net cash from operating activities.
• The company successfully refinanced a portion of its debt obligations.

Negatives

• The company experienced a net loss of $28.3 million in Q3 2024, a significant increase from the $11.2 million loss in Q3 2023.
• Operating expenses increased by 15% year-over-year, primarily due to higher professional services fees and compensation expenses.
• The company's legacy locations saw a decrease in revenue due to increased competition.
• The company's cash and cash equivalents decreased to $65.3 million as of September 30, 2024.

Risks

• The company faces risks related to the volatility of its stock price and liquidity.
• The company's ability to attract and maintain key personnel is a risk.
• The company's ability to continue to open new dispensaries and cultivation facilities as anticipated is a risk.
• The illegality of cannabis under federal law poses a risk to the company.
• The company faces risks related to compliance with state and federal regulations.
• The company faces risks related to restricted access to banking and other financial services.
• The company faces risks related to unfavorable tax treatment for cannabis businesses.
• The company faces risks related to intense competition in the industry.
• The company faces risks related to the maturation of the cannabis market.
• The company faces risks related to adverse changes in wholesale and retail prices.
• The company faces risks related to sustained inflation.
• The company faces risks related to political and economic instability.
• The company faces risks related to outbreaks of pandemic diseases.
• The company faces risks related to general economic conditions.

Future Outlook

The company expects continued growth to be driven by opening new operational facilities and dispensaries under current licenses, expansion of current facilities, and increased consumer demand. The company anticipates capital expenditures of approximately $10,000 to $15,000 during the remainder of 2024 related to certain expansion projects.

Management Comments

• Management believes that substantial doubt of our ability to continue as a going concern for at least one year from the issuance of our Financial Statements has been alleviated due to: (i) cash on hand and (ii) continued growth of sales from our consolidated operations.
• Management plans to continue to access capital markets for additional funding through debt and/or equity financings to supplement future cash needs, as may be required.

Industry Context

The cannabis industry is experiencing increased competition, particularly in mature markets like Illinois, New Jersey, and Massachusetts, which is impacting pricing and revenue for companies like Ascend Wellness Holdings. The company is also navigating the complexities of state and federal regulations, as well as the challenges of operating in a federally illegal industry.

Comparison to Industry Standards

• While specific competitor data is not provided in this document, the flat revenue growth and increased net loss suggest that Ascend Wellness Holdings is facing similar challenges as other multi-state operators in the cannabis industry, including pricing pressures and increased operating costs.
• The company's gross profit margin of 30.9% is within the range of other cannabis companies, but the increased operating expenses are a concern.
• The company's debt refinancing is a common strategy in the industry to manage capital structure and fund growth, but the high interest rates on the new debt may impact future profitability.
• The company's expansion into new markets like Ohio is a positive sign, but the success of these ventures will depend on the regulatory environment and consumer demand.

Management Changes

Legal Proceedings

• The company is involved in ongoing litigation with MedMen NY, Inc. related to a terminated investment agreement.
• The company has established a reserve of $5.4 million related to amounts it is pursuing in the MedMen NY litigation.

Related Party Transactions

• The company has a secured promissory note with a retail dispensary license holder in Massachusetts, partially owned by an entity managed by one of the company's founders.

Stakeholder Impact

• Shareholders may be concerned about the company's increased net loss and decreased cash position.
• Employees may be affected by strategic streamlining in certain departments.
• Customers may experience changes in product availability and pricing due to market competition.
• Suppliers may be impacted by the company's financial performance and capital allocation decisions.
• Creditors may be concerned about the company's debt levels and ability to repay obligations.

Next Steps

• The company plans to continue to access capital markets for additional funding through debt and/or equity financings.
• The company anticipates capital expenditures of approximately $10,000 to $15,000 during the remainder of 2024 related to certain expansion projects.
• The company expects to open a new retail location by the end of 2024.

Key Dates

Keywords

cannabis, multi-state operator, dispensaries, cultivation, wholesale, retail, financial results, debt refinancing, operating expenses, net loss